NCT04874324View on ClinicalTrials.gov

Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of Oral WCK 2349

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

March 17, 2011

Primary Completion Date

May 4, 2011

Study Completion Date

June 25, 2011

Conditions
Pharmacokinetics
Interventions
DRUG

WCK 2349 Oral

1 dose given orally twice daily at 12 hourly interval for five days.

OTHER

Placebo Oral

Subjects will receive matching placebo

Sponsors

Lead Sponsor

Wockhardt
All Listed Sponsors
lead

Wockhardt

INDUSTRY

NCT04874324 - Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of Oral WCK 2349 | Biotech Hunter | Biotech Hunter